BEAT:NSD-Heartbeam Inc (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 1.54

Change

-0.05 (-3.14)%

Market Cap

USD 0.01B

Volume

0.15M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


BEAT Stock Forecast & Price:
Based on the Heartbeam Inc stock forecasts from 0 analysts, the average analyst target price for Heartbeam Inc is not available over the next 12 months. Heartbeam Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Heartbeam Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Heartbeam Inc’s stock price was USD 1.54. Heartbeam Inc’s stock price has changed by +2.67% over the past week, +12.42% over the past month and 0% over the last year.

About Heartbeam Inc (BEAT:NSD)

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patien ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-10 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CERN Cerner Corp

N/A

USD27.92B 48.06 18.97
CHNG Change Healthcare Inc

+0.29 (+1.19%)

USD7.73B N/A 15.20
RCM R1 RCM Inc

+0.33 (+1.28%)

USD7.43B 43.55 35.15
INOV Inovalon Holdings Inc

N/A

USD6.37B 122.57 33.93
HQY HealthEquity Inc

-0.11 (-0.18%)

USD5.16B 789.30 55.52
TXG 10X Genomics Inc

+2.00 (+4.45%)

USD4.83B N/A -81.27
OMCL Omnicell Inc

+2.09 (+1.99%)

USD4.65B 71.59 33.83
PINC Premier Inc

+0.60 (+1.58%)

USD4.48B 15.94 10.44
PGNY Progyny Inc

+4.02 (+9.84%)

USD4.02B 56.73 133.27
CERT Certara Inc

-2.48 (-10.86%)

USD3.79B N/A 61.27

ETFs Containing BEAT

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -50.00% 34% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.00% 34% F 23% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -95.54% 6% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -95.54% 6% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain 8.39% 56% F 66% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.39% 53% F 63% D
Risk Return Profile  
Volatility (Standard Deviation) 52.60% 38% F 26% F
Risk Adjusted Return 15.95% 44% F 51% F
Market Capitalization 0.01B 9% F 4% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 149.92 26% F 8% F
Price/Book Ratio 0.98 84% B 78% C+
Price / Cash Flow Ratio -3,920.90 100% A+ 99% A+
EV/EBITDA -3.90 68% D+ 76% C
Management Effectiveness  
Return on Equity -175.78% 9% F 8% F
Return on Invested Capital 958.90% 97% A+ 99% A+
Return on Assets -41.53% 8% F 8% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 1.80 77% C+ 66% D
Short Percent 1.22% 80% B- 71% C-
Beta 1.31 29% F 33% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector